ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

10812	Companies
234229	Keywords
163017	Articles
125239	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 03/23/2026 at 21:05, 4 months 14 days ago

Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Abivax reports full year 2025 financial results and key business updates, including safety updates, pivotal Phase 3 trial progress, senior leadership appointments, and upcoming milestones. Strong cash position and strategic plans highlighted

Financial Results Abivax Phase 3 Trial Leadership Appointments Business Updates
BRIEF

published on 02/26/2026 at 18:05, 5 months 9 days ago

ABIVAX : Actualisation sur le Capital Social et les Droits de Vote

Euronext Paris Droits De Vote Capital Social Actions Abivax
BRIEF

published on 02/26/2026 at 18:05, 5 months 9 days ago

ABIVAX: Update on Share Capital and Voting Rights

Euronext Paris Share Capital Voting Rights Shares Abivax
PRESS RELEASE

published on 02/26/2026 at 18:00, 5 months 9 days ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.01.26.
ABIVAX communique le nombre d'actions et de droits de vote au 31 janvier 2026. Informations réglementaires conformes au Code de Commerce et au règlement de l'AMF

Droits De Vote Actions AMF Abivax Réglementaire
BRIEF

published on 02/21/2026 at 12:05, 5 months 14 days ago

Abivax Unveils Promising Obefazimod Data at ECCO 2026

Obefazimod Clinical Efficacy Safety Profile Inflammatory Bowel Disease Anti-Fibrotic Activity
BRIEF

published on 02/21/2026 at 12:05, 5 months 14 days ago

Abivax dévoile des données prometteuses sur l'obefazimod lors du salon ECCO 2026

Obefazimod Efficacité Clinique Profil De Sécurité Maladie Inflammatoire De L'intestin Activité Antifibrotique
PRESS RELEASE

published on 02/21/2026 at 12:00, 5 months 14 days ago

Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Abivax présente de nouvelles données sur l'efficacité clinique et l'activité antifibrotique d'obefazimod dans le traitement des maladies inflammatoires chroniques de l'intestin au Congrès de l'ECCO 2026

Abivax Obefazimod Maladie De Crohn Maladies Inflammatoires Fibrose
PRESS RELEASE

published on 02/21/2026 at 12:00, 5 months 14 days ago

Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Abivax présente les preuves d’une activité antifibrotique d'obefazimod et de nouvelles analyses de son efficacité et de sécurité dans les MICI au Congrès de l’ECCO 2026

Abivax Obefazimod Sécurité Efficacité Clinique Activité Antifibrotique
PRESS RELEASE

published on 02/21/2026 at 12:00, 5 months 14 days ago

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Abivax presents first evidence of anti-fibrotic activity for Obefazimod and new clinical efficacy and safety analyses in inflammatory bowel disease at ECCO 2026

Abivax Obefazimod Clinical Efficacy Inflammatory Bowel Disease Anti-fibrotic
BRIEF

published on 01/26/2026 at 18:05, 6 months 12 days ago

ABIVAX: Share capital and voting rights as of December 31, 2025

Voting Rights Biotechnology Actions AMF Abivax

Accesswire

Published on 08/07/2026 at 14:17, 6 hours 37 minutes ago

NuRAN Wireless Increases Series A Preferred Share Financing to C$7.6 Million and Announces Debt Settlements
Published on 08/07/2026 at 13:00, 7 hours 54 minutes ago

Gold Terra Announces Start of Drilling on the Campbell Shear Northern Zone 103N Extension to Expand 2026 MRE of Inferred 595,000 Ounces, Con Mine, Yellowknife, NWT
Published on 08/07/2026 at 00:45, 20 hours 9 minutes ago

NXT Energy Solutions Announces Second Quarter 2026 Results
Published on 08/06/2026 at 23:15, 21 hours 39 minutes ago

LNG Energy Group Announces Issuance of Second Partial Revocation Order and Further Details on Private Placement Financing
Published on 08/06/2026 at 22:15, 22 hours 39 minutes ago

Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada

View all ACCESSWIRE

EQS Group

Published on 08/07/2026 at 19:30, 1 hour 24 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 1 hour 39 minutes ago

ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 2 hours 44 minutes ago

Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 2 hours 54 minutes ago

E-PANGO: Composition du capital au 31 juillet 2026
Published on 08/07/2026 at 17:45, 3 hours 9 minutes ago

Schroder ETFs ICAV: Publication of the Audited Annual Report for Switzerland

Les Echos

Published on 08/07/2026 at 18:54, 2 hours ago

Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 2 hours ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 2 hours 14 minutes ago

Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 2 hours 14 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 2 hours 54 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026

View all LES ECHOS COMFI WIRE